Global Pediatric Medicines

Pediatric Medicines Comprehensive Study by Application (Hospital, Clinic), Forms (Capsule, Liquid, Ointment, Powder), Diseases (Anemia, Chickenpox, Fever, Asthma, Others), Distribution Channel (Online, Offline) Players and Region - Global Market Outlook to 2027

Pediatric Medicines Market by XX Submarkets | Forecast Years 2022-2027  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Pediatric is known as a medicine branch which deals with the health and medical care of children, infants who are up to the age of 18. Pediatric medicines used to cure various types of diseases like viral fever, asthma, tuberculosis, cough etc. Due to the covid-19 situation, these drugs were highly in sales in socio economical region as well as in all over the world. Amoxicillin is one of the most used ingredient in pediatric medicines. The sales of tablets which are used to cure viral fever and cold were increases rapidly in past two years due to pandemics. Similarly the sales of cough syrups also increases. Pandemics also helps the pediatric medicines manufacturing companies to grow in a market. Many small medicine manufacture companies were emerge in a market due to the covid-19.This growth is primarily driven by Increasing Number of Covid-19 Cases .

AttributesDetails
Study Period2017-2027
Base Year2021
Forecast Period2022-2027
Volume UnitN
Value UnitValue (USD Million)
Key Companies in StudyEli Lilly & Co.(United States), Johnson & Johnson (United States), Pfizer ( United States), Abbott Laboratories(United States), AbbVie(United States), Bristol Myers Squibb( United States), LabCorp (United States), Roche (Switzerland), Novartis (Switzerland), Allianz Care(Ireland), Biopolis (Singapore) and Takeda (Japan)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Globally, a noticeable market trend is evident Heavy Progress in Medical Industries as Well as In Research and Development. Major Players, such as Eli Lilly & Co.(United States), Johnson & Johnson (United States), Pfizer ( United States), Abbott Laboratories(United States), AbbVie(United States), Bristol Myers Squibb( United States), LabCorp (United States), Roche (Switzerland), Novartis (Switzerland), Allianz Care(Ireland), Biopolis (Singapore) and Takeda (Japan) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
On July 20, 2021, Eli Lilly and Company Recently Entered into A Pharma Acquisition Deal with Biotechnology Company, Protomer Technologies, To Advance Treatment for Type 1 Diabetes (TD1). Protomer Technologies Is Engineering Next-Generation Protein Therapeutics. The Company’s Peptide and Protein-Engineering Platform Is Used to Identify and Synthesize Molecules That Can Sense Glucose or Other Endogenous Modulators Of Protein Activity.
In 2020, Started Expanding the Follow The Sun Initiative To LabCorp Drug Development Site In India. By The End Of 2021, Aim to Add A Team Of Approximately 100 Nonclinical Specialists To Support The Lab Sites And Studies Around The World With Data Entry, Analytics, Quality Reviews And Reports.In This Market Major Players Are Taking Initiatives To Meet Their Organic And Inorganic Strategy Growth, Companies Are Investing In Product Portfolio And Also Focusing Towards Enhancing Their Global Reach.

Regulatory Insights:
On June 11, 2022, AbbVie Announced Primary Results from The Large B-Cell Lymphoma (LBCL) Expansion Cohort in the EPCORE NHL-1 Phase 2 Clinical Trial Evaluating Epcoritamab An Investigational Subcutaneous Bispecific Antibody. In This Study, Epcoritamab Demonstrated Efficacy with Durable Responses In Patients Who Had Previously Received At Least Two Prior Lines Of Anti-Lymphoma Therapy Including Chimeric Antigen Receptor (CAR) T-Cell Therapy. These Data Were Presented Today In A Late-Breaking Oral Presentation As A Part Of The Presidential Symposium At The 27th Annual Meeting Of The European Hematology Association (EHA2022) In Vienna, Austria.

Market Drivers
  • Increasing Number of Covid-19 Cases
  • Rising Cases of Nutritional Allergies in Children

Market Trend
  • Heavy Progress in Medical Industries as Well as In Research and Development

Restraints
  • Excessive Consume of Medicine Shows Bad Effects on Health of Children
  • Harmful Ingredients Found in Some Drugs

Opportunities
Growing Healthcare Infrastructure and Increasing investment of player in R &D pediatric Medicines
Challenges
Lack of availability of Drugs Targeting Rare Pediatric Diseases

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Pediatric Medicines Study Sheds Light on
— The Pediatric Medicines Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Pediatric Medicines industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Pediatric Medicines industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Application
  • Hospital
  • Clinic
By Forms
  • Capsule
  • Liquid
  • Ointment
  • Powder

By Diseases
  • Anemia
  • Chickenpox
  • Fever
  • Asthma
  • Others

By Distribution Channel
  • Online
  • Offline

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Covid-19 Cases
      • 3.2.2. Rising Cases of Nutritional Allergies in Children
    • 3.3. Market Challenges
      • 3.3.1. Lack of availability of Drugs Targeting Rare Pediatric Diseases
    • 3.4. Market Trends
      • 3.4.1. Heavy Progress in Medical Industries as Well as In Research and Development
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pediatric Medicines, by Application, Forms, Diseases , Distribution Channel and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Pediatric Medicines (Value)
      • 5.2.1. Global Pediatric Medicines by: Application (Value)
        • 5.2.1.1. Hospital
        • 5.2.1.2. Clinic
      • 5.2.2. Global Pediatric Medicines by: Forms (Value)
        • 5.2.2.1. Capsule
        • 5.2.2.2. Liquid
        • 5.2.2.3. Ointment
        • 5.2.2.4. Powder
      • 5.2.3. Global Pediatric Medicines by: Distribution Channel (Value)
        • 5.2.3.1. Online
        • 5.2.3.2. Offline
      • 5.2.4. Global Pediatric Medicines Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Pediatric Medicines (Price)
  • 6. Pediatric Medicines: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Eli Lilly & Co.(United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Johnson & Johnson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Pfizer ( United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Abbott Laboratories(United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AbbVie(United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Bristol Myers Squibb( United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. LabCorp (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Roche (Switzerland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Novartis (Switzerland)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Allianz Care(Ireland)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Biopolis (Singapore)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Takeda (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Pediatric Medicines Sale, by Application, Forms, Diseases , Distribution Channel and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Pediatric Medicines (Value)
      • 7.2.1. Global Pediatric Medicines by: Application (Value)
        • 7.2.1.1. Hospital
        • 7.2.1.2. Clinic
      • 7.2.2. Global Pediatric Medicines by: Forms (Value)
        • 7.2.2.1. Capsule
        • 7.2.2.2. Liquid
        • 7.2.2.3. Ointment
        • 7.2.2.4. Powder
      • 7.2.3. Global Pediatric Medicines by: Distribution Channel (Value)
        • 7.2.3.1. Online
        • 7.2.3.2. Offline
      • 7.2.4. Global Pediatric Medicines Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Pediatric Medicines (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pediatric Medicines: by Application(USD Million)
  • Table 2. Pediatric Medicines Hospital , by Region USD Million (2016-2021)
  • Table 3. Pediatric Medicines Clinic , by Region USD Million (2016-2021)
  • Table 4. Pediatric Medicines: by Forms(USD Million)
  • Table 5. Pediatric Medicines Capsule , by Region USD Million (2016-2021)
  • Table 6. Pediatric Medicines Liquid , by Region USD Million (2016-2021)
  • Table 7. Pediatric Medicines Ointment , by Region USD Million (2016-2021)
  • Table 8. Pediatric Medicines Powder , by Region USD Million (2016-2021)
  • Table 9. Pediatric Medicines: by Distribution Channel(USD Million)
  • Table 10. Pediatric Medicines Online , by Region USD Million (2016-2021)
  • Table 11. Pediatric Medicines Offline , by Region USD Million (2016-2021)
  • Table 12. South America Pediatric Medicines, by Country USD Million (2016-2021)
  • Table 13. South America Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 14. South America Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 15. South America Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 16. South America Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 17. Brazil Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 18. Brazil Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 19. Brazil Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 20. Brazil Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 21. Argentina Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 22. Argentina Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 23. Argentina Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 24. Argentina Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 25. Rest of South America Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 26. Rest of South America Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 27. Rest of South America Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 28. Rest of South America Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 29. Asia Pacific Pediatric Medicines, by Country USD Million (2016-2021)
  • Table 30. Asia Pacific Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 31. Asia Pacific Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 32. Asia Pacific Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 33. Asia Pacific Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 34. China Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 35. China Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 36. China Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 37. China Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 38. Japan Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 39. Japan Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 40. Japan Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 41. Japan Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 42. India Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 43. India Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 44. India Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 45. India Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 46. South Korea Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 47. South Korea Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 48. South Korea Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 49. South Korea Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 50. Australia Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 51. Australia Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 52. Australia Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 53. Australia Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 57. Rest of Asia-Pacific Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 58. Europe Pediatric Medicines, by Country USD Million (2016-2021)
  • Table 59. Europe Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 60. Europe Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 61. Europe Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 62. Europe Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 63. Germany Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 64. Germany Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 65. Germany Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 66. Germany Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 67. France Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 68. France Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 69. France Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 70. France Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 71. Italy Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 72. Italy Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 73. Italy Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 74. Italy Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 75. United Kingdom Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 76. United Kingdom Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 77. United Kingdom Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 78. United Kingdom Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 79. Netherlands Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 80. Netherlands Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 81. Netherlands Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 82. Netherlands Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 83. Rest of Europe Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 84. Rest of Europe Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 85. Rest of Europe Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 86. Rest of Europe Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 87. MEA Pediatric Medicines, by Country USD Million (2016-2021)
  • Table 88. MEA Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 89. MEA Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 90. MEA Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 91. MEA Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 92. Middle East Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 93. Middle East Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 94. Middle East Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 95. Middle East Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 96. Africa Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 97. Africa Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 98. Africa Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 99. Africa Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 100. North America Pediatric Medicines, by Country USD Million (2016-2021)
  • Table 101. North America Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 102. North America Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 103. North America Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 104. North America Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 105. United States Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 106. United States Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 107. United States Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 108. United States Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 109. Canada Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 110. Canada Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 111. Canada Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 112. Canada Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 113. Mexico Pediatric Medicines, by Application USD Million (2016-2021)
  • Table 114. Mexico Pediatric Medicines, by Forms USD Million (2016-2021)
  • Table 115. Mexico Pediatric Medicines, by Diseases USD Million (2016-2021)
  • Table 116. Mexico Pediatric Medicines, by Distribution Channel USD Million (2016-2021)
  • Table 117. Company Basic Information, Sales Area and Its Competitors
  • Table 118. Company Basic Information, Sales Area and Its Competitors
  • Table 119. Company Basic Information, Sales Area and Its Competitors
  • Table 120. Company Basic Information, Sales Area and Its Competitors
  • Table 121. Company Basic Information, Sales Area and Its Competitors
  • Table 122. Company Basic Information, Sales Area and Its Competitors
  • Table 123. Company Basic Information, Sales Area and Its Competitors
  • Table 124. Company Basic Information, Sales Area and Its Competitors
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Pediatric Medicines: by Application(USD Million)
  • Table 130. Pediatric Medicines Hospital , by Region USD Million (2022-2027)
  • Table 131. Pediatric Medicines Clinic , by Region USD Million (2022-2027)
  • Table 132. Pediatric Medicines: by Forms(USD Million)
  • Table 133. Pediatric Medicines Capsule , by Region USD Million (2022-2027)
  • Table 134. Pediatric Medicines Liquid , by Region USD Million (2022-2027)
  • Table 135. Pediatric Medicines Ointment , by Region USD Million (2022-2027)
  • Table 136. Pediatric Medicines Powder , by Region USD Million (2022-2027)
  • Table 137. Pediatric Medicines: by Distribution Channel(USD Million)
  • Table 138. Pediatric Medicines Online , by Region USD Million (2022-2027)
  • Table 139. Pediatric Medicines Offline , by Region USD Million (2022-2027)
  • Table 140. South America Pediatric Medicines, by Country USD Million (2022-2027)
  • Table 141. South America Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 142. South America Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 143. South America Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 144. South America Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 145. Brazil Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 146. Brazil Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 147. Brazil Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 148. Brazil Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 149. Argentina Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 150. Argentina Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 151. Argentina Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 152. Argentina Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 153. Rest of South America Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 154. Rest of South America Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 155. Rest of South America Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 156. Rest of South America Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 157. Asia Pacific Pediatric Medicines, by Country USD Million (2022-2027)
  • Table 158. Asia Pacific Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 159. Asia Pacific Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 160. Asia Pacific Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 161. Asia Pacific Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 162. China Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 163. China Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 164. China Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 165. China Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 166. Japan Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 167. Japan Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 168. Japan Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 169. Japan Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 170. India Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 171. India Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 172. India Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 173. India Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 174. South Korea Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 175. South Korea Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 176. South Korea Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 177. South Korea Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 178. Australia Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 179. Australia Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 180. Australia Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 181. Australia Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 182. Rest of Asia-Pacific Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 183. Rest of Asia-Pacific Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 184. Rest of Asia-Pacific Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 185. Rest of Asia-Pacific Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 186. Europe Pediatric Medicines, by Country USD Million (2022-2027)
  • Table 187. Europe Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 188. Europe Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 189. Europe Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 190. Europe Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 191. Germany Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 192. Germany Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 193. Germany Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 194. Germany Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 195. France Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 196. France Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 197. France Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 198. France Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 199. Italy Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 200. Italy Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 201. Italy Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 202. Italy Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 203. United Kingdom Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 204. United Kingdom Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 205. United Kingdom Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 206. United Kingdom Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 207. Netherlands Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 208. Netherlands Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 209. Netherlands Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 210. Netherlands Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 211. Rest of Europe Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 212. Rest of Europe Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 213. Rest of Europe Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 214. Rest of Europe Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 215. MEA Pediatric Medicines, by Country USD Million (2022-2027)
  • Table 216. MEA Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 217. MEA Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 218. MEA Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 219. MEA Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 220. Middle East Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 221. Middle East Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 222. Middle East Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 223. Middle East Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 224. Africa Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 225. Africa Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 226. Africa Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 227. Africa Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 228. North America Pediatric Medicines, by Country USD Million (2022-2027)
  • Table 229. North America Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 230. North America Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 231. North America Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 232. North America Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 233. United States Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 234. United States Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 235. United States Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 236. United States Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 237. Canada Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 238. Canada Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 239. Canada Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 240. Canada Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 241. Mexico Pediatric Medicines, by Application USD Million (2022-2027)
  • Table 242. Mexico Pediatric Medicines, by Forms USD Million (2022-2027)
  • Table 243. Mexico Pediatric Medicines, by Diseases USD Million (2022-2027)
  • Table 244. Mexico Pediatric Medicines, by Distribution Channel USD Million (2022-2027)
  • Table 245. Research Programs/Design for This Report
  • Table 246. Key Data Information from Secondary Sources
  • Table 247. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Pediatric Medicines: by Application USD Million (2016-2021)
  • Figure 5. Global Pediatric Medicines: by Forms USD Million (2016-2021)
  • Figure 6. Global Pediatric Medicines: by Distribution Channel USD Million (2016-2021)
  • Figure 7. South America Pediatric Medicines Share (%), by Country
  • Figure 8. Asia Pacific Pediatric Medicines Share (%), by Country
  • Figure 9. Europe Pediatric Medicines Share (%), by Country
  • Figure 10. MEA Pediatric Medicines Share (%), by Country
  • Figure 11. North America Pediatric Medicines Share (%), by Country
  • Figure 12. Global Pediatric Medicines share by Players 2021 (%)
  • Figure 13. Global Pediatric Medicines share by Players (Top 3) 2021(%)
  • Figure 14. Global Pediatric Medicines share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Eli Lilly & Co.(United States) Revenue, Net Income and Gross profit
  • Figure 17. Eli Lilly & Co.(United States) Revenue: by Geography 2021
  • Figure 18. Johnson & Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 19. Johnson & Johnson (United States) Revenue: by Geography 2021
  • Figure 20. Pfizer ( United States) Revenue, Net Income and Gross profit
  • Figure 21. Pfizer ( United States) Revenue: by Geography 2021
  • Figure 22. Abbott Laboratories(United States) Revenue, Net Income and Gross profit
  • Figure 23. Abbott Laboratories(United States) Revenue: by Geography 2021
  • Figure 24. AbbVie(United States) Revenue, Net Income and Gross profit
  • Figure 25. AbbVie(United States) Revenue: by Geography 2021
  • Figure 26. Bristol Myers Squibb( United States) Revenue, Net Income and Gross profit
  • Figure 27. Bristol Myers Squibb( United States) Revenue: by Geography 2021
  • Figure 28. LabCorp (United States) Revenue, Net Income and Gross profit
  • Figure 29. LabCorp (United States) Revenue: by Geography 2021
  • Figure 30. Roche (Switzerland) Revenue, Net Income and Gross profit
  • Figure 31. Roche (Switzerland) Revenue: by Geography 2021
  • Figure 32. Novartis (Switzerland) Revenue, Net Income and Gross profit
  • Figure 33. Novartis (Switzerland) Revenue: by Geography 2021
  • Figure 34. Allianz Care(Ireland) Revenue, Net Income and Gross profit
  • Figure 35. Allianz Care(Ireland) Revenue: by Geography 2021
  • Figure 36. Biopolis (Singapore) Revenue, Net Income and Gross profit
  • Figure 37. Biopolis (Singapore) Revenue: by Geography 2021
  • Figure 38. Takeda (Japan) Revenue, Net Income and Gross profit
  • Figure 39. Takeda (Japan) Revenue: by Geography 2021
  • Figure 40. Global Pediatric Medicines: by Application USD Million (2022-2027)
  • Figure 41. Global Pediatric Medicines: by Forms USD Million (2022-2027)
  • Figure 42. Global Pediatric Medicines: by Distribution Channel USD Million (2022-2027)
  • Figure 43. South America Pediatric Medicines Share (%), by Country
  • Figure 44. Asia Pacific Pediatric Medicines Share (%), by Country
  • Figure 45. Europe Pediatric Medicines Share (%), by Country
  • Figure 46. MEA Pediatric Medicines Share (%), by Country
  • Figure 47. North America Pediatric Medicines Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Eli Lilly & Co.(United States)
  • Johnson & Johnson (United States)
  • Pfizer ( United States)
  • Abbott Laboratories(United States)
  • AbbVie(United States)
  • Bristol Myers Squibb( United States)
  • LabCorp (United States)
  • Roche (Switzerland)
  • Novartis (Switzerland)
  • Allianz Care(Ireland)
  • Biopolis (Singapore)
  • Takeda (Japan)
Additional players considered in the study are as follows:
Shanghai Pharmaceuticals(China) , Astellas Pharma Inc.(Japan) , Astrazeneca Plc(United Kingdom) , Medi quest Pharma(India) , Divi’s Laboratories(India)
Select User Access Type

Key Highlights of Report


Jun 2022 229 Pages 65 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Pediatric Medicines Quantitative research analysis
Global Pediatric Medicines Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2017-2021; Base year: 2021; Forecast period: 2022 to 2027
Companies that are profiled in Global Pediatric Medicines Market are Eli Lilly & Co.(United States), Johnson & Johnson (United States), Pfizer ( United States), Abbott Laboratories(United States), AbbVie(United States), Bristol Myers Squibb( United States), LabCorp (United States), Roche (Switzerland), Novartis (Switzerland), Allianz Care(Ireland), Biopolis (Singapore) and Takeda (Japan) etc.
Hospital segment in Global market to hold robust market share owing to "Increasing Number of Covid-19 Cases ".
AMA Research predicts that United States Players will contribute to the maximum growth of Global Pediatric Medicines market throughout the forecasted period.

Know More About Global Pediatric Medicines Report?

Have a Query? Click Here

Other Related Reports

Anesthesia Masks Comprehensive Study by Type (Oral {Reusable Anesthesia Face Mask and Disposable Anesthesia Face Mask}, Nasopharyngeal {Reusable Anesthesia Face Mask and Disposable Anesthesia Face Ma...
$ 3650
Skin Care Peels Comprehensive Study by Type (TCA Peels, Lactic Peels, Beta Peels, Glycolic Chemical Peels, Vitalize Peels, Pigment Balancing Peels, Bio Revitalization Peel, Other), Treatment (Acne Tr...
$ 3800
Oil Softgel Capsules Comprehensive Study by Type (Fish Oil, Krill Oil, Pumpkin Seed Oil, Other), Application (Pharmaceutical, Health Supplements, Others), Distribution Channel (Online, Offline), Tech...
$ 3350
Cannabidiol Comprehensive Study by Type (Marijuana-Derived Cannabidiol Products, Hemp-Derived Cannabidiol Products), Application (Personal Care & Cosmetics, Pharmaceutical (Anxiety, Fibromyalgia (FM)...
$ 3650
Active Pharmaceutical Ingredients Comprehensive Study by Type (Innovative Active Pharmaceutical Ingredients, Generic Active Pharmaceutical Ingredients), Synthesis (Biotech, Synthetic), Manufacturer (...
$ 3750
Nootropics Comprehensive Study by Application (ADHD, Alzheimer, Narcolepsy, Memory Enhancement, Mood and Depression, Anxiety, Others), Drug (Prescription (Modafinil, Adderall, Methylphenidate, Memant...
$ 3750